Chondrocyte apoptosis in the pathogenesis of osteoarthritis

International Journal of Molecular Sciences

Volumn 16, Issue 11, 2015, Pages 26035-26054

  Hwang, Hyun Sook ^a   Kim, Hyun Ah ^a  

^a Hallym University   (South Korea)

Author keywords

Apoptosis; Autophagy; Cartilage; Caspase; Chondrocyte; Chondroptosis; Endoplasmic reticulum stress; Mitochondria; Osteoarthritis

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; ALPHA INTERFERON; CASPASE; CASPASE 10; CASPASE 11; CASPASE 12; CASPASE 13; CASPASE 2; CASPASE 3; CASPASE 4; CASPASE 5; CASPASE 6; CASPASE 7; CASPASE 8; CASPASE 9; INTERLEUKIN 1BETA; INTERLEUKIN 1BETA CONVERTING ENZYME; MAMMALIAN TARGET OF RAPAMYCIN; MATRIX METALLOPROTEINASE; MICRORNA; MICRORNA 146A; MYELOID DIFFERENTIATION FACTOR 88; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN BCL 2; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE; TOLL LIKE RECEPTOR; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND RECEPTOR; VASCULOTROPIN; ANTIINFLAMMATORY AGENT; BIOLOGICAL MARKER;

APOPTOSIS; AUTOPHAGY; CARTILAGE CELL; CELL DIFFERENTIATION; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; CHRONIC LYMPHATIC LEUKEMIA; DOWN REGULATION; ENDOPLASMIC RETICULUM STRESS; HUMAN; OSTEOARTHRITIS; OXIDATIVE STRESS; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REVIEW; SENESCENCE; SIGNAL TRANSDUCTION; UNFOLDED PROTEIN RESPONSE; UPREGULATION; ANIMAL; CHONDROCYTE; DRUG EFFECTS; METABOLISM; MITOCHONDRION; MOLECULARLY TARGETED THERAPY;

ANIMALS; ANTI-INFLAMMATORY AGENTS; APOPTOSIS; BIOMARKERS; CHONDROCYTES; HUMANS; MITOCHONDRIA; MOLECULAR TARGETED THERAPY; OSTEOARTHRITIS; SIGNAL TRANSDUCTION;

EID: 84946088396     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms161125943     Document Type: Review

References (144)

1. Kerr, J.F.; Wyllie, A.H.; Currie, A.R. Apoptosis: A basic biological phenomenon with wide-ranging implications in tissue kinetics. Br. J. Cancer 1972, 26, 239–257. [CrossRef] [PubMed]
2. Hacker, G. The morphology of apoptosis. Cell Tissue Res. 2000, 301, 5–17. [CrossRef] [PubMed]
3. Greenhalgh, D.G. The role of apoptosis in wound healing. Int. J. Biochem. Cell Biol. 1998, 30, 1019–1030. [CrossRef]
4. Tiwari, M.; Prasad, S.; Tripathi, A.; Pandey, A.N.; Ali, I.; Singh, A.K.; Shrivastav, T.G.; Chaube, S.K. Apoptosis in mammalian oocytes: A review. Apoptosis 2015, 20, 1019–1025. [CrossRef] [PubMed]
5. Lund, L.R.; Romer, J.; Thomasset, N.; Solberg, H.; Pyke, C.; Bissell, M.J.; Dano, K.; Werb, Z. Two distinct phases of apoptosis in mammary gland involution: Proteinase-independent and -dependent pathways. Development 1996, 122, 181–193. [PubMed]
6. Croce, C.M. Causes and consequences of microRNA dysregulation in cancer. Nat. Rev. Genet. 2009, 10, 704–714. [CrossRef] [PubMed]
7. Fulda, S. Tumor resistance to apoptosis. Int. J. Cancer 2009, 124, 511–515. [CrossRef] [PubMed]
8. Galluzzi, L.; Morselli, E.; Kepp, O.; Vitale, I.; Rigoni, A.; Vacchelli, E.; Michaud, M.; Zischka, H.; Castedo, M.; Kroemer, G. Mitochondrial gateways to cancer. Mol. Asp. Med. 2010, 31, 1–20. [CrossRef] [PubMed]
9. Delbridge, A.R.; Strasser, A. The Bcl-2 protein family, BH3-mimetics and cancer therapy. Cell Death Differ. 2015, 22, 1071–1080. [CrossRef] [PubMed]
10. Goldar, S.; Khaniani, M.S.; Derakhshan, S.M.; Baradaran, B. Molecular mechanisms of apoptosis and roles in cancer development and treatment. Asian Pac. J. Cancer Prev. 2015, 16, 2129–2144. [CrossRef] [PubMed]
11. Guicciardi, M.E.; Gores, G.J. Life and death by death receptors. FASEB J. 2009, 23, 1625–1637. [CrossRef] [PubMed]
12. Li, C.J.; Friedman, D.J.; Wang, C.; Metelev, V.; Pardee, A.B. Induction of apoptosis in uninfected lymphocytes by HIV-1 Tat protein. Science 1995, 268, 429–431. [CrossRef] [PubMed]
13. Hroudova, J.; Singh, N.; Fisar, Z. Mitochondrial dysfunctions in neurodegenerative diseases: Relevance to Alzheimer’s disease. Biomed Res. Int. 2014, 2014, 175062. [CrossRef] [PubMed]
14. Viswanath, V.; Wu, Y.; Boonplueang, R.; Chen, S.; Stevenson, F.F.; Yantiri, F.; Yang, L.; Beal, M.F.; Andersen, J.K. Caspase-9 activation results in downstream caspase-8 activation and bid cleavage in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson’s disease. J. Neurosci. 2001, 21, 9519–9528. [PubMed]
15. Li, J.; Yuan, J. Caspases in apoptosis and beyond. Oncogene 2008, 27, 6194–6206. [CrossRef] [PubMed]
16. Pop, C.; Salvesen, G.S. Human caspases: Activation, specificity, and regulation. J. Biol. Chem. 2009, 284, 21777–21781. [CrossRef] [PubMed]
17. Howley, B.; Fearnhead, H.O. Caspases as therapeutic targets. J. Cell. Mol. Med. 2008, 12, 1502–1516. [CrossRef] [PubMed]
18. Labbe, K.; Saleh, M. Cell death in the host response to infection. Cell Death Differ. 2008, 15, 1339–1349. [CrossRef] [PubMed]
19. Martinon, F.; Tschopp, J. Inflammatory caspases and inflammasomes: Master switches of inflammation. Cell Death Differ. 2007, 14, 10–22. [CrossRef] [PubMed]
20. Shi, J.; Zhao, Y.; Wang, Y.; Gao, W.; Ding, J.; Li, P.; Hu, L.; Shao, F. Inflammatory caspases are innate immune receptors for intracellular LPS. Nature 2014, 514, 187–192. [CrossRef] [PubMed]
21. Hunter, A.M.; LaCasse, E.C.; Korneluk, R.G. The inhibitors of apoptosis (IAPs) as cancer targets. Apoptosis 2007, 12, 1543–1568. [CrossRef] [PubMed]
22. Eckelman, B.P.; Salvesen, G.S. The human anti-apoptotic proteins cIAP1 and cIAP2 bind but do not inhibit caspases. J. Biol. Chem. 2006, 281, 3254–3260. [CrossRef] [PubMed]
23. Blankenship, J.W.; Varfolomeev, E.; Goncharov, T.; Fedorova, A.V.; Kirkpatrick, D.S.; Izrael-Tomasevic, A.; Phu, L.; Arnott, D.; Aghajan, M.; Zobel, K. et al. Ubiquitin binding modulates IAP antagonist-stimulated proteasomal degradation of c-IAP1 and c-IAP2(1). Biochem. J. 2009, 417, 149–160. [CrossRef] [PubMed]
24. Micheau, O.; Thome, M.; Schneider, P.; Holler, N.; Tschopp, J.; Nicholson, D.W.; Briand, C.; Grutter, M.G. The long form of FLIP is an activator of caspase-8 at the Fas death-inducing signaling complex. J. Biol. Chem. 2002, 277, 45162–45171. [CrossRef] [PubMed]
25. Van Delft, M.F.; Huang, D.C. How the Bcl-2 family of proteins interact to regulate apoptosis. Cell Res. 2006, 16, 203–213. [CrossRef] [PubMed]
26. Adams, J.M.; Cory, S. Life-or-death decisions by the Bcl-2 protein family. Trends Biochem. Sci. 2001, 26, 61–66. [CrossRef]
27. Sattler, M.; Liang, H.; Nettesheim, D.; Meadows, R.P.; Harlan, J.E.; Eberstadt, M.; Yoon, H.S.; Shuker, S.B.; Chang, B.S.; Minn, A.J. et al. Structure of Bcl-xL-Bak peptide complex: Recognition between regulators of apoptosis. Science 1997, 275, 983–986. [CrossRef] [PubMed]
28. Liu, X.; Dai, S.; Zhu, Y.; Marrack, P.; Kappler, J.W. The structure of a Bcl-xL/Bim fragment complex: Implications for Bim function. Immunity 2003, 19, 341–352. [CrossRef]
29. Hinds, M.G.; Lackmann, M.; Skea, G.L.; Harrison, P.J.; Huang, D.C.; Day, C.L. The structure of Bcl-w reveals a role for the C-terminal residues in modulating biological activity. EMBO J. 2003, 22, 1497–1507. [CrossRef] [PubMed]
30. Elmore, S. Apoptosis: A review of programmed cell death. Toxicol. Pathol. 2007, 35, 495–516. [CrossRef] [PubMed]
31. Ashkenazi, A.; Dixit, V.M. Death receptors: Signaling and modulation. Science 1998, 281, 1305–1308. [CrossRef] [PubMed]
32. Du, C.; Fang, M.; Li, Y.; Li, L.; Wang, X. Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition. Cell 2000, 102, 33–42. [CrossRef]
33. Chinnaiyan, A.M. The apoptosome: Heart and soul of the cell death machine. Neoplasia 1999, 1, 5–15. [CrossRef] [PubMed]
34. Van Loo, G.; van Gurp, M.; Depuydt, B.; Srinivasula, S.M.; Rodriguez, I.; Alnemri, E.S.; Gevaert, K.; Vandekerckhove, J.; Declercq, W.; Vandenabeele, P. The serine protease Omi/HtrA2 is released from mitochondria during apoptosis. Omi interacts with caspase-inhibitor XIAP and induces enhanced caspase activity. Cell Death Differ. 2002, 9, 20–26. [CrossRef] [PubMed]
35. Schimmer, A.D. Inhibitor of apoptosis proteins: Translating basic knowledge into clinical practice. Cancer Res. 2004, 64, 7183–7190. [CrossRef] [PubMed]
36. Subasinghe, W.; Syed, I.; Kowluru, A. Phagocyte-like NADPH oxidase promotes cytokine-induced mitochondrial dysfunction in pancreatic _-cells: Evidence for regulation by Rac1. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2011, 300, R12–R20. [CrossRef] [PubMed]
37. Hiebert, P.R.; Granville, D.J. Granzyme B in injury, inflammation, and repair. Trends Mol. Med. 2012, 18, 732–741. [CrossRef] [PubMed]
38. Buzza, M.S.; Zamurs, L.; Sun, J.; Bird, C.H.; Smith, A.I.; Trapani, J.A.; Froelich, C.J.; Nice, E.C.; Bird, P.I. Extracellular matrix remodeling by human granzyme B via cleavage of vitronectin, fibronectin, and laminin. J. Biol. Chem. 2005, 280, 23549–23558. [CrossRef] [PubMed]
39. Park, N.R.; Lim, K.E.; Han, M.S.; Che, X.; Park, C.; Kim, J.E.; Taniuchi, I.; Bae, S.C.; Choi, J.Y. Core binding factor _ plays a critical role during chondrocyte differentiation. J. Cell. Physiol. 2016, 231, 162–171. [CrossRef] [PubMed]
40. Rabie, A.B.; Tang, G.H.; Hagg, U. Cbfa1 couples chondrocytes maturation and endochondral ossification in rat mandibular condylar cartilage. Arch. Oral Biol. 2004, 49, 109–118. [CrossRef] [PubMed]
41. Hoemann, C.D.; Tran-Khanh, N.; Chevrier, A.; Chen, G.; Lascau-Coman, V.; Mathieu, C.; Changoor, A.; Yaroshinsky, A.; McCormack, R.G.; Stanish, W.D. et al. Chondroinduction is the main cartilage repair response to microfracture and microfracture with BST-CarGel: Results as shown by ICRS-II histological scoring and a novel zonal collagen type scoring method of human clinical biopsy specimens. Am. J. Sports Med. 2015. [CrossRef] [PubMed]
42. Lee, P.; Tran, K.; Zhou, G.; Bedi, A.; Shelke, N.B.; Yu, X.; Kumbar, S.G. Guided differentiation of bone marrow stromal cells on co-cultured cartilage and bone scaffolds. Soft Matter 2015, 11, 7648–7655. [CrossRef] [PubMed]
43. Li, S.; Yang, X.; Tang, S.; Zhang, X.; Feng, Z.; Cui, S. Repair of massively defected hemi-joints using demineralized osteoarticular allografts with protected cartilage. J. Mater. Sci. Mater. Med. 2015, 26, 277. [CrossRef] [PubMed]
44. McMahon, L.A.; O’Brien, F.J.; Prendergast, P.J. Biomechanics and mechanobiology in osteochondral tissues. Regen. Med. 2008, 3, 743–759. [CrossRef] [PubMed]
45. Yang, X.; Teguh, D.; Wu, J.P.; He, B.; Kirk, T.B.; Qin, S.; Li, S.; Chen, H.; Xue, W.; Ng, B. et al. Protein kinase C delta null mice exhibit structural alterations in articular surface, intra-articular and subchondral compartments. Arthritis Res. Ther. 2015, 17, 210. [CrossRef] [PubMed]
46. Adams, C.S.; Horton, W.E., Jr. Chondrocyte apoptosis increases with age in the articular cartilage of adult animals. Anat. Rec. 1998, 250, 418–425. [CrossRef]
47. Kim, H.A.; Blanco, F.J. Cell death and apoptosis in osteoarthritic cartilage. Curr. Drug Targets 2007, 8, 333–345. [CrossRef] [PubMed]
48. Kop’eva, T.N.; Bel’skaia, O.B.; Astapenko, M.G.; Arutiunov, A.G. Morphology of articular cartilage in osteoarthrosis. Arkh. Patol. 1986, 48, 40–46. [PubMed]
49. Aigner, T.; Hemmel, M.; Neureiter, D.; Gebhard, P.M.; Zeiler, G.; Kirchner, T.; McKenna, L. Apoptotic cell death is not a widespread phenomenon in normal aging and osteoarthritis human articular knee cartilage: A study of proliferation, programmed cell death (apoptosis), and viability of chondrocytes in normal and osteoarthritic human knee cartilage. Arthritis Rheumatol. 2001, 44, 1304–1312.
50. Heraud, F.; Heraud, A.; Harmand, M.F. Apoptosis in normal and osteoarthritic human articular cartilage. Ann. Rheum. Dis. 2000, 59, 959–965. [CrossRef] [PubMed]
51. Aigner, T.; Kim, H.A.; Roach, H.I. Apoptosis in osteoarthritis. Rheum. Dis. Clin. N. Am 2004, 30, 639–653. [CrossRef] [PubMed]
52. Jiao, K.; Zhang, J.; Zhang, M.; Wei, Y.; Wu, Y.; Qiu, Z.Y.; He, J.; Cao, Y.; Hu, J.; Zhu, H. et al. The identification of CD163 expressing phagocytic chondrocytes in joint cartilage and its novel scavenger role in cartilage degradation. PLoS ONE 2013, 8, e53312. [CrossRef] [PubMed]
53. Kim, H.A.; Suh, D.I.; Song, Y.W. Relationship between chondrocyte apoptosis and matrix depletion in human articular cartilage. J. Rheumatol. 2001, 28, 2038–2045. [PubMed]
54. Pulai, J.I.; del Carlo, M., Jr.; Loeser, R.F. The _5_1 integrin provides matrix survival signals for normal and osteoarthritic human articular chondrocytes in vitro. Arthritis Rheumatol. 2002, 46, 1528–1535. [CrossRef] [PubMed]
55. Zemmyo, M.; Meharra, E.J.; Kuhn, K.; Creighton-Achermann, L.; Lotz, M. Accelerated, aging-dependent development of osteoarthritis in _1 integrin-deficient mice. Arthritis Rheumatol. 2003, 48, 2873–2880. [CrossRef] [PubMed]
56. Zamli, Z.; Sharif, M. Chondrocyte apoptosis: A cause or consequence of osteoarthritis? Int. J. Rheum. Dis. 2011, 14, 159–166. [CrossRef] [PubMed]
57. Blanco, F.J.; Ochs, R.L.; Schwarz, H.; Lotz, M. Chondrocyte apoptosis induced by nitric oxide. Am. J. Pathol. 1995, 146, 75–85. [PubMed]
58. Borge, L.; Demignot, S.; Adolphe, M. Type II transglutaminase expression in rabbit articular chondrocytes in culture: Relation with cell differentiation, cell growth, cell adhesion and cell apoptosis. Biochim. Biophys. Acta 1996, 1312, 117–124. [CrossRef]
59. Hashimoto, S.; Setareh, M.; Ochs, R.L.; Lotz, M. Fas/Fas ligand expression and induction of apoptosis in chondrocytes. Arthritis Rheumatol. 1997, 40, 1749–1755. [CrossRef]
60. Ishizaki, Y.; Burne, J.F.; Raff, M.C. Autocrine signals enable chondrocytes to survive in culture. J. Cell Biol. 1994, 126, 1069–1077. [CrossRef] [PubMed]
61. Kim, H.A.; Kim, Y.H.; Song, Y.W. Facilitation of Fas mediated apoptosis of human chondrocytes by the proteasome inhibitor and actinomycin D. J. Rheumatol. 2003, 30, 550–558. [PubMed]
62. Pelletier, J.P.; Mineau, F.; Ranger, P.; Tardif, G.; Martel-Pelletier, J. The increased synthesis of inducible nitric oxide inhibits IL-1ra synthesis by human articular chondrocytes: Possible role in osteoarthritic cartilage degradation. Osteoarthr. Cartil. 1996, 4, 77–84. [CrossRef]
63. Studer, R.K.; Levicoff, E.; Georgescu, H.; Miller, L.; Jaffurs, D.; Evans, C.H. Nitric oxide inhibits chondrocyte response to IGF-I: Inhibition of IGF-IR_ tyrosine phosphorylation. Am. J. Physiol. Cell Physiol. 2000, 279, C961–C969.[PubMed]
64. Del Carlo, M., Jr.; Loeser, R.F. Nitric oxide-mediated chondrocyte cell death requires the generation of additional reactive oxygen species. Arthritis Rheumatol. 2002, 46, 394–403. [CrossRef] [PubMed]
65. Kuhn, K.; D’Lima, D.D.; Hashimoto, S.; Lotz, M. Cell death in cartilage. Osteoarthr. Cartil. 2004, 12, 1–16. [CrossRef] [PubMed]
66. Whiteman, M.; Armstrong, J.S.; Cheung, N.S.; Siau, J.L.; Rose, P.; Schantz, J.T.; Jones, D.P.; Halliwell, B. Peroxynitrite mediates calcium-dependent mitochondrial dysfunction and cell death via activation of calpains. FASEB J. 2004, 18, 1395–1397. [CrossRef] [PubMed]
67. Schuerwegh, A.J.; Dombrecht, E.J.; Stevens, W.J.; van Offel, J.F.; Bridts, C.H.; de Clerck, L.S. Influence of pro-inflammatory (IL-1_, IL-6, TNF-_, IFN-) and anti-inflammatory (IL-4) cytokines on chondrocyte function. Osteoarthr. Cartil. 2003, 11, 681–687. [CrossRef]
68. Kuhn, K.; Hashimoto, S.; Lotz, M. IL-1_ protects human chondrocytes from CD95-induced apoptosis. J. Immunol. 2000, 164, 2233–2239. [CrossRef] [PubMed]
69. Pettersen, I.; Figenschau, Y.; Olsen, E.; Bakkelund, W.; Smedsrod, B.; Sveinbjornsson, B. Tumor necrosis factor-related apoptosis-inducing ligand induces apoptosis in human articular chondrocytes in vitro. Biochem. Biophys. Res. Commun. 2002, 296, 671–676. [CrossRef]
70. Lee, S.W.; Lee, H.J.; Chung, W.T.; Choi, S.M.; Rhyu, S.H.; Kim, D.K.; Kim, K.T.; Kim, J.Y.; Kim, J.M.; Yoo, Y.H. TRAIL induces apoptosis of chondrocytes and influences the pathogenesis of experimentally induced rat osteoarthritis. Arthritis Rheumatol. 2004, 50, 534–542. [CrossRef] [PubMed]
71. Sena, P.; Manfredini, G.; Benincasa, M.; Mariani, F.; Smargiassi, A.; Catani, F.; Palumbo, C. Up-regulation of the chemo-attractive receptor ChemR23 and occurrence of apoptosis in human chondrocytes isolated from fractured calcaneal osteochondral fragments. J. Anat. 2014, 224, 659–668. [CrossRef] [PubMed]
72. Maneiro, E.; Martin, M.A.; de Andres, M.C.; Lopez-Armada, M.J.; Fernandez-Sueiro, J.L.; del Hoyo, P.; Galdo, F.; Arenas, J.; Blanco, F.J. Mitochondrial respiratory activity is altered in osteoarthritic human articular chondrocytes. Arthritis Rheumatol. 2003, 48, 700–708. [CrossRef] [PubMed]
73. Ruiz-Romero, C.; Calamia, V.; Mateos, J.; Carreira, V.; Martinez-Gomariz, M.; Fernandez, M.; Blanco, F.J. Mitochondrial dysregulation of osteoarthritic human articular chondrocytes analyzed by proteomics: A decrease in mitochondrial superoxide dismutase points to a redox imbalance. Mol. Cell. Proteom. 2009, 8, 172–189. [CrossRef] [PubMed]
74. Grishko, V.I.; Druzhyna, N.; LeDoux, S.P.; Wilson, G.L. Nitric oxide-induced damage to mtDNA and its subsequent repair. Nucleic Acids Res. 1999, 27, 4510–4516. [CrossRef] [PubMed]
75. Feng, L.; Precht, P.; Balakir, R.; Horton, W.E., Jr. Evidence of a direct role for Bcl-2 in the regulation of articular chondrocyte apoptosis under the conditions of serum withdrawal and retinoic acid treatment. J. Cell. Biochem. 1998, 71, 302–309. [CrossRef]
76. Engels, B.M.; Hutvagner, G. Principles and effects of microRNA-mediated post-transcriptional gene regulation. Oncogene 2006, 25, 6163–6169. [CrossRef] [PubMed]
77. Miyaki, S.; Sato, T.; Inoue, A.; Otsuki, S.; Ito, Y.; Yokoyama, S.; Kato, Y.; Takemoto, F.; Nakasa, T.; Yamashita, S. et al. MicroRNA-140 plays dual roles in both cartilage development and homeostasis. Genes Dev. 2010, 24, 1173–1185. [CrossRef] [PubMed]
78. Taganov, K.D.; Boldin, M.P.; Chang, K.J.; Baltimore, D. NF-_B-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc. Natl. Acad. Sci. USA 2006, 103, 12481–12486. [CrossRef] [PubMed]
79. Yamasaki, K.; Nakasa, T.; Miyaki, S.; Ishikawa, M.; Deie, M.; Adachi, N.; Yasunaga, Y.; Asahara, H.; Ochi, M. Expression of MicroRNA-146a in osteoarthritis cartilage. Arthritis Rheumatol. 2009, 60, 1035–1041. [CrossRef] [PubMed]
80. Jin, L.; Zhao, J.; Jing, W.; Yan, S.; Wang, X.; Xiao, C.; Ma, B. Role of miR-146a in human chondrocyte apoptosis in response to mechanical pressure injury in vitro. Int. J. Mol. Med. 2014, 34, 451–463. [CrossRef] [PubMed]
81. Li, J.; Huang, J.; Dai, L.; Yu, D.; Chen, Q.; Zhang, X.; Dai, K. miR-146a, an IL-1_ responsive miRNA, induces vascular endothelial growth factor and chondrocyte apoptosis by targeting Smad4. Arthritis Res. Ther. 2012, 14, R75. [CrossRef] [PubMed]
82. Hobert, O. Gene regulation by transcription factors and microRNAs. Science 2008, 319, 1785–1786. [CrossRef] [PubMed]
83. Mobasheri, A.; Matta, C.; Zakany, R.; Musumeci, G. Chondrosenescence: Definition, hallmarks and potential role in the pathogenesis of osteoarthritis. Maturitas 2015, 80, 237–244. [CrossRef] [PubMed]
84. Johnson, K.; Pritzker, K.; Goding, J.; Terkeltaub, R. The nucleoside triphosphate pyrophosphohydrolase isozyme PC-1 directly promotes cartilage calcification through chondrocyte apoptosis and increased calcium precipitation by mineralizing vesicles. J. Rheumatol. 2001, 28, 2681–2691. [PubMed]
85. Hashimoto, S.; Ochs, R.L.; Rosen, F.; Quach, J.; McCabe, G.; Solan, J.; Seegmiller, J.E.; Terkeltaub, R.; Lotz, M. Chondrocyte-derived apoptotic bodies and calcification of articular cartilage. Proc. Natl. Acad. Sci. USA 1998, 95, 3094–3099. [CrossRef] [PubMed]
86. Carlo, M.D., Jr.; Loeser, R.F. Increased oxidative stresswith aging reduces chondrocyte survival: Correlation with intracellular glutathione levels. Arthritis Rheumatol. 2003, 48, 3419–3430. [CrossRef] [PubMed]
87. Franceschi, C.; Capri, M.; Monti, D.; Giunta, S.; Olivieri, F.; Sevini, F.; Panourgia, M.P.; Invidia, L.; Celani, L.; Scurti, M. et al. Inflammaging and anti-inflammaging: A systemic perspective on aging and longevity emerged from studies in humans. Mech. Ageing Dev. 2007, 128, 92–105. [CrossRef] [PubMed]
88. Carames, B.; Taniguchi, N.; Otsuki, S.; Blanco, F.J.; Lotz, M. Autophagy is a protective mechanism in normal cartilage, and its aging-related loss is linked with cell death and osteoarthritis. Arthritis Rheumatol. 2010, 62, 791–801. [CrossRef] [PubMed]
89. De Groot, J.; Verzijl, N.; Wenting-van Wijk, M.J.; Jacobs, K.M.; van El, B.; van Roermund, P.M.; Bank, R.A.; Bijlsma, J.W.; TeKoppele, J.M.; Lafeber, F.P. Accumulation of advanced glycation end products as a molecular mechanism for aging as a risk factor in osteoarthritis. Arthritis Rheumatol. 2004, 50, 1207–1215. [CrossRef] [PubMed]
90. Kim, J.H.; Lee, G.; Won, Y.; Lee, M.; Kwak, J.S.; Chun, C.H.; Chun, J.S. Matrix cross-linking-mediated mechanotransduction promotes posttraumatic osteoarthritis. Proc. Natl. Acad. Sci. USA 2015, 112, 9424–9429. [CrossRef] [PubMed]
91. Yamabe, S.; Hirose, J.; Uehara, Y.; Okada, T.; Okamoto, N.; Oka, K.; Taniwaki, T.; Mizuta, H. Intracellular accumulation of advanced glycation end products induces apoptosis via endoplasmic reticulum stress in chondrocytes. FEBS J. 2013, 280, 1617–1629. [CrossRef] [PubMed]
92. Guerne, P.A.; Blanco, F.; Kaelin, A.; Desgeorges, A.; Lotz, M. Growth factor responsiveness of human articular chondrocytes in aging and development. Arthritis Rheumatol. 1995, 38, 960–968. [CrossRef]
93. Loeser, R.F.; Gandhi, U.; Long, D.L.; Yin, W.; Chubinskaya, S. Aging and oxidative stress reduce the response of human articular chondrocytes to insulin-like growth factor 1 and osteogenic protein 1. Arthritis Rheumatol. 2014, 66, 2201–2209. [CrossRef] [PubMed]
94. Mizushima, N.; Komatsu, M. Autophagy: Renovation of cells and tissues. Cell 2011, 147, 728–741. [CrossRef] [PubMed]
95. Huang, J.; Lam, G.Y.; Brumell, J.H. Autophagy signaling through reactive oxygen species. Antioxid. Redox Signal. 2011, 14, 2215–2231. [CrossRef] [PubMed]
96. Vasheghani, F.; Zhang, Y.; Li, Y.H.; Blati, M.; Fahmi, H.; Lussier, B.; Roughley, P.; Lagares, D.; Endisha, H.; Saffar, B. et al. PPAR deficiency results in severe, accelerated osteoarthritis associated with aberrant mTOR signalling in the articular cartilage. Ann. Rheum. Dis. 2015, 74, 569–578. [CrossRef] [PubMed]
97. Bertacchini, J.; Heidari, N.; Mediani, L.; Capitani, S.; Shahjahani, M.; Ahmadzadeh, A.; Saki, N. Targeting PI3K/AKT/mTOR network for treatment of leukemia. Cell. Mol. Life Sci. 2015, 72, 2337–2247. [CrossRef] [PubMed]
98. Bohensky, J.; Terkhorn, S.P.; Freeman, T.A.; Adams, C.S.; Garcia, J.A.; Shapiro, I.M.; Srinivas, V. Regulation of autophagy in human and murine cartilage: Hypoxia-inducible factor 2 suppresses chondrocyte autophagy. Arthritis Rheumatol. 2009, 60, 1406–1415. [CrossRef] [PubMed]
99. Kim, D.H.; Sarbassov, D.D.; Ali, S.M.; King, J.E.; Latek, R.R.; Erdjument-Bromage, H.; Tempst, P.; Sabatini, D.M. mTOR interacts with raptor to form a nutrient-sensitive complex that signals to the cell growth machinery. Cell 2002, 110, 163–175. [CrossRef]
100. Knowles, M.A.; Platt, F.M.; Ross, R.L.; Hurst, C.D. Phosphatidylinositol 3-kinase (PI3K) pathway activation in bladder cancer. Cancer Metastasis Rev. 2009, 28, 305–316. [CrossRef] [PubMed]
101. Sasaki, H.; Takayama, K.; Matsushita, T.; Ishida, K.; Kubo, S.; Matsumoto, T.; Fujita, N.; Oka, S.; Kurosaka, M.; Kuroda, R. Autophagy modulates osteoarthritis-related gene expression in human chondrocytes. Arthritis Rheumatol. 2012, 64, 1920–1928. [CrossRef] [PubMed]
102. Maiuri, M.C.; Zalckvar, E.; Kimchi, A.; Kroemer, G. Self-eating and self-killing: Crosstalk between autophagy and apoptosis. Nat. Rev. Mol. Cell Biol. 2007, 8, 741–752. [CrossRef] [PubMed]
103. Maiuri, M.C.; Le Toumelin, G.; Criollo, A.; Rain, J.C.; Gautier, F.; Juin, P.; Tasdemir, E.; Pierron, G.; Troulinaki, K.; Tavernarakis, N. et al. Functional and physical interaction between Bcl-XL and a BH3-like domain in Beclin-1. EMBO J. 2007, 26, 2527–2539. [CrossRef] [PubMed]
104. Sinha, S.; Levine, B. The autophagy effector Beclin 1: A novel BH3-only protein. Oncogene 2008, 27 (Suppl. 1), S137–S148. [CrossRef] [PubMed]
105. Wirawan, E.; Vande Walle, L.; Kersse, K.; Cornelis, S.; Claerhout, S.; Vanoverberghe, I.; Roelandt, R.; de Rycke, R.; Verspurten, J.; Declercq, W. et al. Caspase-mediated cleavage of Beclin-1 inactivates Beclin-1-induced autophagy and enhances apoptosis by promoting the release of proapoptotic factors from mitochondria. Cell Death Dis. 2010, 1, e18. [CrossRef] [PubMed]
106. Lee, J.S.; Li, Q.; Lee, J.Y.; Lee, S.H.; Jeong, J.H.; Lee, H.R.; Chang, H.; Zhou, F.C.; Gao, S.J.; Liang, C. et al. FLIP-mediated autophagy regulation in cell death control. Nat. Cell Biol. 2009, 11, 1355–1362. [CrossRef] [PubMed]
107. Eisenberg-Lerner, A.; Bialik, S.; Simon, H.U.; Kimchi, A. Life and death partners: Apoptosis, autophagy and the cross-talk between them. Cell Death Differ. 2009, 16, 966–975. [CrossRef] [PubMed]
108. Carames, B.; Hasegawa, A.; Taniguchi, N.; Miyaki, S.; Blanco, F.J.; Lotz, M. Autophagy activation by rapamycin reduces severity of experimental osteoarthritis. Ann. Rheum. Dis. 2012, 71, 575–581. [CrossRef] [PubMed]
109. Carames, B.; Taniguchi, N.; Seino, D.; Blanco, F.J.; D’Lima, D.; Lotz, M. Mechanical injury suppresses autophagy regulators and pharmacologic activation of autophagy results in chondroprotection. Arthritis Rheumatol. 2012, 64, 1182–1192. [CrossRef] [PubMed]
110. Hui, W.; Young, D.A.; Rowan, A.D.; Xu, X.; Cawston, T.E.; Proctor, C.J. Oxidative changes and signalling pathways are pivotal in initiating age-related changes in articular cartilage. Ann. Rheum. Dis. 2014. [CrossRef] [PubMed]
111. Liu, N.; Wang, W.; Zhao, Z.; Zhang, T.; Song, Y. Autophagy in human articular chondrocytes is cytoprotective following glucocorticoid stimulation. Mol. Med. Rep. 2014, 9, 2166–2172. [CrossRef] [PubMed]
112. Lopez de Figueroa, P.; Lotz, M.K.; Blanco, F.J.; Carames, B. Autophagy activation and protection from mitochondrial dysfunction in human chondrocytes. Arthritis Rheumatol. 2015, 67, 966–976. [CrossRef] [PubMed]
113. Chang, J.; Wang, W.; Zhang, H.; Hu, Y.; Wang, M.; Yin, Z. The dual role of autophagy in chondrocyte responses in the pathogenesis of articular cartilage degeneration in osteoarthritis. Int. J. Mol. Med. 2014, 32, 1311–1318.
114. Uehara, Y.; Hirose, J.; Yamabe, S.; Okamoto, N.; Okada, T.; Oyadomari, S.; Mizuta, H. Endoplasmic reticulum stress-induced apoptosis contributes to articular cartilage degeneration via C/EBP homologous protein. Osteoarthr. Cartil. 2014, 22, 1007–1017. [CrossRef] [PubMed]
115. Gotoh, T.; Endo, M.; Oike, Y. Endoplasmic reticulum stress-related inflammation and cardiovascular diseases. Int. J. Inflam. 2011, 2011, 259462. [CrossRef] [PubMed]
116. Oyadomari, S.; Koizumi, A.; Takeda, K.; Gotoh, T.; Akira, S.; Araki, E.; Mori, M. Targeted disruption of the Chop gene delays endoplasmic reticulum stress-mediated diabetes. J. Clin. Investig. 2002, 109, 525–532. [CrossRef] [PubMed]
117. Puthalakath, H.; O’Reilly, L.A.; Gunn, P.; Lee, L.; Kelly, P.N.; Huntington, N.D.; Hughes, P.D.; Michalak, E.M.; McKimm-Breschkin, J.; Motoyama, N. et al. ER stress triggers apoptosis by activating BH3-only protein Bim. Cell 2007, 129, 1337–1349. [CrossRef] [PubMed]
118. Hiramatsu, N.; Chiang, W.C.; Kurt, T.D.; Sigurdson, C.J.; Lin, J.H. Multiple Mechanisms of Unfolded Protein Response-Induced Cell Death. Am. J. Pathol. 2015, 185, 1800–1808. [CrossRef] [PubMed]
119. Nugent, A.E.; Speicher, D.M.; Gradisar, I.; McBurney, D.L.; Baraga, A.; Doane, K.J.; Horton, W.E., Jr. Advanced osteoarthritis in humans is associated with altered collagen VI expression and upregulation of ER-stress markers Grp78 and bag-1. J. Histochem. Cytochem. 2009, 57, 923–931. [CrossRef] [PubMed]
120. Takada, K.; Hirose, J.; Senba, K.; Yamabe, S.; Oike, Y.; Gotoh, T.; Mizuta, H. Enhanced apoptotic and reduced protective response in chondrocytes following endoplasmic reticulum stress in osteoarthritic cartilage. Int. J. Exp. Pathol. 2011, 92, 232–242. [CrossRef] [PubMed]
121. Hamamura, K.; Goldring, M.B.; Yokota, H. Involvement of p38 MAPK in regulation of MMP13 mRNA in chondrocytes in response to surviving stress to endoplasmic reticulum. Arch. Oral Biol. 2009, 54, 279–286. [CrossRef] [PubMed]
122. Husa, M.; Petursson, F.; Lotz, M.; Terkeltaub, R.; Liu-Bryan, R. C/EBP homologous protein drives pro-catabolic responses in chondrocytes. Arthritis Res. Ther. 2013, 15, R218. [CrossRef] [PubMed]
123. Yang, L.; Carlson, S.G.; McBurney, D.; Horton, W.E., Jr. Multiple signals induce endoplasmic reticulum stress in both primary and immortalized chondrocytes resulting in loss of differentiation, impaired cell growth, and apoptosis. J. Biol. Chem. 2005, 280, 31156–31165. [CrossRef] [PubMed]
124. Ruiz-Romero, C.; Carreira, V.; Rego, I.; Remeseiro, S.; Lopez-Armada, M.J.; Blanco, F.J. Proteomic analysis of human osteoarthritic chondrocytes reveals protein changes in stress and glycolysis. Proteomics 2008, 8, 495–507. [CrossRef] [PubMed]
125. Carloni, S.; Albertini, M.C.; Galluzzi, L.; Buonocore, G.; Proietti, F.; Balduini, W. Increased autophagy reduces endoplasmic reticulum stress after neonatal hypoxia-ischemia: Role of protein synthesis and autophagic pathways. Exp. Neurol. 2014, 255, 103–112. [CrossRef] [PubMed]
126. Horiuchi, K.; Saito, S.; Sasaki, R.; Tomatsu, T.; Toyama, Y. Expression of granzyme B in human articular chondrocytes. J. Rheumatol. 2003, 30, 1799–1810. [PubMed]
127. Saito, S.; Murakoshi, K.; Kotake, S.; Kamatani, N.; Tomatsu, T. Granzyme B induces apoptosis of chondrocytes with natural killer cell-like cytotoxicity in rheumatoid arthritis. J. Rheumatol. 2008, 35, 1932–1943. [PubMed]
128. Wang, Q.; Rozelle, A.L.; Lepus, C.M.; Scanzello, C.R.; Song, J.J.; Larsen, D.M.; Crish, J.F.; Bebek, G.; Ritter, S.Y.; Lindstrom, T.M. et al. Identification of a central role for complement in osteoarthritis. Nat. Med. 2011, 17, 1674–1679. [CrossRef] [PubMed]
129. Bohana-Kashtan, O.; Ziporen, L.; Donin, N.; Kraus, S.; Fishelson, Z. Cell signals transduced by complement. Mol. Immunol. 2004, 41, 583–597. [CrossRef] [PubMed]
130. Mistry, D.; Oue, Y.; Chambers, M.G.; Kayser, M.V.; Mason, R.M. Chondrocyte death during murine osteoarthritis. Osteoarthr. Cartil. 2004, 12, 131–141. [CrossRef] [PubMed]
131. Coustry, F.; Posey, K.L.; Liu, P.; Alcorn, J.L.; Hecht, J.T. D469del-COMP retention in chondrocytes stimulates caspase-independent necroptosis. Am. J. Pathol. 2012, 180, 738–748. [CrossRef] [PubMed]
132. Lo, M.Y.; Kim, H.T. Chondrocyte apoptosis induced by collagen degradation: Inhibition by caspase inhibitors and IGF-1. J. Orthop. Res. 2004, 22, 140–144. [CrossRef]
133. Lopez-Armada, M.J.; Carames, B.; Cillero-Pastor, B.; Lires-Dean, M.; Maneiro, E.; Fuentes, I.; Ruiz, C.; Galdo, F.; Blanco, F.J. Phosphatase-1 and -2A inhibition modulates apoptosis in human osteoarthritis chondrocytes independently of nitric oxide production. Ann. Rheum. Dis. 2005, 64, 1079–1082. [CrossRef] [PubMed]
134. Nuttall, M.E.; Nadeau, D.P.; Fisher, P.W.; Wang, F.; Keller, P.M.; DeWolf, W.E., Jr.; Goldring, M.B.; Badger, A.M.; Lee, D.; Levy, M.A. et al. Inhibition of caspase-3-like activity prevents apoptosis while retaining functionality of human chondrocytes in vitro. J. Orthop. Res. 2000, 18, 356–363. [CrossRef] [PubMed]
135. Pelletier, J.P.; Fernandes, J.C.; Jovanovic, D.V.; Reboul, P.; Martel-Pelletier, J. Chondrocyte death in experimental osteoarthritis is mediated by MEK 1/2 and p38 pathways: Role of cyclooxygenase-2 and inducible nitric oxide synthase. J. Rheumatol. 2001, 28, 2509–2519. [PubMed]
136. Loening, A.M.; James, I.E.; Levenston, M.E.; Badger, A.M.; Frank, E.H.; Kurz, B.; Nuttall, M.E.; Hung, H.H.; Blake, S.M.; Grodzinsky, A.J. et al. Injurious mechanical compression of bovine articular cartilage induces chondrocyte apoptosis. Arch. Biochem. Biophys. 2000, 381, 205–212. [CrossRef] [PubMed]
137. D’Lima, D.; Hermida, J.; Hashimoto, S.; Colwell, C.; Lotz, M. Caspase inhibitors reduce severity of cartilage lesions in experimental osteoarthritis. Arthritis Rheumatol. 2006, 54, 1814–1821. [CrossRef] [PubMed]
138. Lotz, M.K.; Kraus, V.B. New developments in osteoarthritis. Posttraumatic osteoarthritis: Pathogenesis and pharmacological treatment options. Arthritis Res. Ther. 2010, 12, 211. [CrossRef] [PubMed]
139. Elsaid, K.A.; Zhang, L.; Shaman, Z.; Patel, C.; Schmidt, T.A.; Jay, G.D. The impact of early intra-articular administration of interleukin-1 receptor antagonist on lubricin metabolism and cartilage degeneration in an anterior cruciate ligament transection model. Osteoarthr. Cartil. 2015, 23, 114–121. [CrossRef] [PubMed]
140. Pelletier, J.P.; Mineau, F.; Boileau, C.; Martel-Pelletier, J. Diacerein reduces the level of cartilage chondrocyte DNA fragmentation and death in experimental dog osteoarthritic cartilage at the same time that it inhibits caspase-3 and inducible nitric oxide synthase. Clin. Exp. Rheumatol. 2003, 21, 171–177. [PubMed]
141. Pelletier, J.P.; Yaron, M.; Haraoui, B.; Cohen, P.; Nahir, M.A.; Choquette, D.; Wigler, I.; Rosner, I.A.; Beaulieu, A.D. Efficacy and safety of diacerein in osteoarthritis of the knee: A double-blind, placebo-controlled trial. The Diacerein Study Group. Arthritis Rheumatol. 2000, 43, 2339–2348. [CrossRef]
142. Takahashi, K.; Hashimoto, S.; Kubo, T.; Hirasawa, Y.; Lotz, M.; Amiel, D. Effect of hyaluronan on chondrocyte apoptosis and nitric oxide production in experimentally induced osteoarthritis. J. Rheumatol. 2000, 27, 1713–1720. [PubMed]
143. De Mattei, M.; Pellati, A.; Pasello, M.; de Terlizzi, F.; Massari, L.; Gemmati, D.; Caruso, A. High doses of glucosamine-HCl have detrimental effects on bovine articular cartilage explants cultured in vitro. Osteoarthr. Cartil. 2002, 10, 816–825. [CrossRef] [PubMed]
144. Zamli, Z.; Robson Brown, K.; Tarlton, J.F.; Adams, M.A.; Torlot, G.E.; Cartwright, C.; Cook, W.A.; Vassilevskaja, K.; Sharif, M. Subchondral bone plate thickening precedes chondrocyte apoptosis and cartilage degradation in spontaneous animal models of osteoarthritis. Biomed Res. Int. 2014, 2014, 606870. [CrossRef] [PubMed]